Proteon Pharmaceuticals
Bacteriophage therapeutics · Salmonella (poultry), aquaculture
Overview
Precision bacteriophage products replacing antibiotics in animal production (BAFASAL for poultry salmonella, BAFADOR for fish) — a Polish leader in applied phage biology.
What they do
Proteon Pharmaceuticals is a Polish biotech and a leader in applied bacteriophage biology, developing precision phage products that reduce reliance on antibiotics in animal production. Its lead products are BAFASAL, targeting Salmonella in poultry, and BAFADOR, a phage cocktail against Pseudomonas and Aeromonas infections in farmed fish (aquaculture).
Lead program & status
BAFASAL is a liquid feed additive built from four strictly virulent bacteriophages, designed to reduce Salmonella Enteritidis and Typhimurium and administered via drinking water or liquid feed across poultry species. After a process Proteon reportedly began in 2017, the EU EFSA issued a supporting opinion in December 2024, EU member states voted in favour in May 2025, and BAFASAL received full EU authorization as a zootechnical feed additive, with the regulation published in the Official Journal on 15 July 2025 and entering into force on 5 August 2025 - reportedly the first bacteriophage-based zootechnical feed additive approved in the EU. BAFADOR targets aquaculture and also acts as a fish immune stimulant.
Why it matters
By replacing antibiotics with targeted phages, Proteon addresses antimicrobial resistance and food-safety pressures, offering a regulatory-validated tool for sustainable animal farming.
FAQ
- What is BAFASAL?
- A bacteriophage-based liquid feed additive that reduces Salmonella in poultry; it received full EU authorization as a zootechnical feed additive in 2025, reportedly the first of its kind in the EU.
- What is BAFADOR used for?
- BAFADOR is a bacteriophage cocktail against Pseudomonas and Aeromonas infections in commercial aquaculture, and it also stimulates the immune system of fish.
- Why use bacteriophages instead of antibiotics?
- Phages target specific bacteria precisely, helping reduce antibiotic use in animal production and addressing antimicrobial resistance and food-safety concerns.
Company website / source ↗ Open the interactive map →
Get ahead of the next biotech boom.
New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.